These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9736816

  • 1. Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
    Rachmani R, Levi Z, Slavachevsky I, Half-Onn E, Ravid M.
    Nephron; 1998 Oct; 80(2):175-82. PubMed ID: 9736816
    [Abstract] [Full Text] [Related]

  • 2. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P, GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators.
    Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 4. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B, Weidmann P, Wohler D, Le Bloch Y.
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 6. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
    Grimm RH, Flack JM, Schoenberger JA, Gonzalez NM, Liebson PR.
    Am J Hypertens; 1996 May; 9(5):445-54. PubMed ID: 8735175
    [Abstract] [Full Text] [Related]

  • 7. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Giordano M, Sanders LR, Castellino P, Canessa ML, DeFronzo RA.
    Nephron; 1996 May; 72(3):447-53. PubMed ID: 8852495
    [Abstract] [Full Text] [Related]

  • 8. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
    Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH.
    Kidney Int; 2003 May; 63(5):1874-80. PubMed ID: 12675866
    [Abstract] [Full Text] [Related]

  • 9. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 10. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    Englert RG, Mauersberger H.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
    [Abstract] [Full Text] [Related]

  • 11. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [Abstract] [Full Text] [Related]

  • 12. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K, Ikarashi T.
    Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
    [Abstract] [Full Text] [Related]

  • 13. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.
    Breithaupt-Grögler K, Leschinger M, Belz GG, Butzer R, Erb K, de May C, Sinn W.
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):49-57. PubMed ID: 8723170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC, Ko GT, Chan WB, Ma RC, So WY, Lo MK, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JC.
    Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V, Escobar C, Tomás JP, Calderon A, Echarri R.
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.